MCP-1 in Alzheimer's disease patients

A-2518G polymorphism and serum levels

Chiara Fenoglio, Daniela Galimberti, Carlo Lovati, Ilaria Guidi, Alberto Gatti, Sergio Fogliarino, Marco Tiriticco, Claudio Mariani, Gianluigi Forloni, Carla Pettenati, Pierluigi Baron, Giancarlo Conti, Nereo Bresolin, Elio Scarpini

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

MCP-1 levels are increased in CSF of patients with Alzheimer's disease (AD) compared with controls, suggesting a role in the development of dementia. Recently, a biallelic A/G polymorphism in the MCP-1 promoter at position -2518 has been found, influencing the level of MCP-1 expression in response to an inflammatory stimulus. The distribution of the A-2518G SNP was determined in 269 AD patients and in 203 healthy age matched controls, showing no differences between the two groups. On the contrary, a significant increase of MCP-1 serum levels in AD patients carrying at least one G mutated allele was observed. Moreover, the highest peaks of MCP-1 serum levels were present in patients carrying two G alleles. Stratifying by ApoE genotype, gender or age at onset, no differences in both allele frequency and MCP-1 serum concentration were observed. The A-2518G polymorphism in MCP-1 gene does not seem to be a risk factor for the development of AD, but its presence correlates with higher levels of serum MCP-1, which can contribute to increase the inflammatory process occurring in AD.

Original languageEnglish
Pages (from-to)1169-1173
Number of pages5
JournalNeurobiology of Aging
Volume25
Issue number9
DOIs
Publication statusPublished - Oct 2004

Fingerprint

Alzheimer Disease
Serum
Alleles
Apolipoproteins E
Age of Onset
Gene Frequency
Single Nucleotide Polymorphism
Dementia
Genotype
Alzheimer disease type 1
Genes

Keywords

  • Alzheimer's disease
  • Chemokines
  • Genetics
  • MCP-1
  • Monocyte chemoattractant protein-1
  • Polymorphism

ASJC Scopus subject areas

  • Clinical Neurology
  • Biological Psychiatry
  • Developmental Neuroscience
  • Neurology
  • Psychology(all)

Cite this

MCP-1 in Alzheimer's disease patients : A-2518G polymorphism and serum levels. / Fenoglio, Chiara; Galimberti, Daniela; Lovati, Carlo; Guidi, Ilaria; Gatti, Alberto; Fogliarino, Sergio; Tiriticco, Marco; Mariani, Claudio; Forloni, Gianluigi; Pettenati, Carla; Baron, Pierluigi; Conti, Giancarlo; Bresolin, Nereo; Scarpini, Elio.

In: Neurobiology of Aging, Vol. 25, No. 9, 10.2004, p. 1169-1173.

Research output: Contribution to journalArticle

Fenoglio, C, Galimberti, D, Lovati, C, Guidi, I, Gatti, A, Fogliarino, S, Tiriticco, M, Mariani, C, Forloni, G, Pettenati, C, Baron, P, Conti, G, Bresolin, N & Scarpini, E 2004, 'MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels', Neurobiology of Aging, vol. 25, no. 9, pp. 1169-1173. https://doi.org/10.1016/j.neurobiolaging.2003.11.008
Fenoglio, Chiara ; Galimberti, Daniela ; Lovati, Carlo ; Guidi, Ilaria ; Gatti, Alberto ; Fogliarino, Sergio ; Tiriticco, Marco ; Mariani, Claudio ; Forloni, Gianluigi ; Pettenati, Carla ; Baron, Pierluigi ; Conti, Giancarlo ; Bresolin, Nereo ; Scarpini, Elio. / MCP-1 in Alzheimer's disease patients : A-2518G polymorphism and serum levels. In: Neurobiology of Aging. 2004 ; Vol. 25, No. 9. pp. 1169-1173.
@article{164fc0db0bcb47fe8983d7c55e2c10ed,
title = "MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels",
abstract = "MCP-1 levels are increased in CSF of patients with Alzheimer's disease (AD) compared with controls, suggesting a role in the development of dementia. Recently, a biallelic A/G polymorphism in the MCP-1 promoter at position -2518 has been found, influencing the level of MCP-1 expression in response to an inflammatory stimulus. The distribution of the A-2518G SNP was determined in 269 AD patients and in 203 healthy age matched controls, showing no differences between the two groups. On the contrary, a significant increase of MCP-1 serum levels in AD patients carrying at least one G mutated allele was observed. Moreover, the highest peaks of MCP-1 serum levels were present in patients carrying two G alleles. Stratifying by ApoE genotype, gender or age at onset, no differences in both allele frequency and MCP-1 serum concentration were observed. The A-2518G polymorphism in MCP-1 gene does not seem to be a risk factor for the development of AD, but its presence correlates with higher levels of serum MCP-1, which can contribute to increase the inflammatory process occurring in AD.",
keywords = "Alzheimer's disease, Chemokines, Genetics, MCP-1, Monocyte chemoattractant protein-1, Polymorphism",
author = "Chiara Fenoglio and Daniela Galimberti and Carlo Lovati and Ilaria Guidi and Alberto Gatti and Sergio Fogliarino and Marco Tiriticco and Claudio Mariani and Gianluigi Forloni and Carla Pettenati and Pierluigi Baron and Giancarlo Conti and Nereo Bresolin and Elio Scarpini",
year = "2004",
month = "10",
doi = "10.1016/j.neurobiolaging.2003.11.008",
language = "English",
volume = "25",
pages = "1169--1173",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - MCP-1 in Alzheimer's disease patients

T2 - A-2518G polymorphism and serum levels

AU - Fenoglio, Chiara

AU - Galimberti, Daniela

AU - Lovati, Carlo

AU - Guidi, Ilaria

AU - Gatti, Alberto

AU - Fogliarino, Sergio

AU - Tiriticco, Marco

AU - Mariani, Claudio

AU - Forloni, Gianluigi

AU - Pettenati, Carla

AU - Baron, Pierluigi

AU - Conti, Giancarlo

AU - Bresolin, Nereo

AU - Scarpini, Elio

PY - 2004/10

Y1 - 2004/10

N2 - MCP-1 levels are increased in CSF of patients with Alzheimer's disease (AD) compared with controls, suggesting a role in the development of dementia. Recently, a biallelic A/G polymorphism in the MCP-1 promoter at position -2518 has been found, influencing the level of MCP-1 expression in response to an inflammatory stimulus. The distribution of the A-2518G SNP was determined in 269 AD patients and in 203 healthy age matched controls, showing no differences between the two groups. On the contrary, a significant increase of MCP-1 serum levels in AD patients carrying at least one G mutated allele was observed. Moreover, the highest peaks of MCP-1 serum levels were present in patients carrying two G alleles. Stratifying by ApoE genotype, gender or age at onset, no differences in both allele frequency and MCP-1 serum concentration were observed. The A-2518G polymorphism in MCP-1 gene does not seem to be a risk factor for the development of AD, but its presence correlates with higher levels of serum MCP-1, which can contribute to increase the inflammatory process occurring in AD.

AB - MCP-1 levels are increased in CSF of patients with Alzheimer's disease (AD) compared with controls, suggesting a role in the development of dementia. Recently, a biallelic A/G polymorphism in the MCP-1 promoter at position -2518 has been found, influencing the level of MCP-1 expression in response to an inflammatory stimulus. The distribution of the A-2518G SNP was determined in 269 AD patients and in 203 healthy age matched controls, showing no differences between the two groups. On the contrary, a significant increase of MCP-1 serum levels in AD patients carrying at least one G mutated allele was observed. Moreover, the highest peaks of MCP-1 serum levels were present in patients carrying two G alleles. Stratifying by ApoE genotype, gender or age at onset, no differences in both allele frequency and MCP-1 serum concentration were observed. The A-2518G polymorphism in MCP-1 gene does not seem to be a risk factor for the development of AD, but its presence correlates with higher levels of serum MCP-1, which can contribute to increase the inflammatory process occurring in AD.

KW - Alzheimer's disease

KW - Chemokines

KW - Genetics

KW - MCP-1

KW - Monocyte chemoattractant protein-1

KW - Polymorphism

UR - http://www.scopus.com/inward/record.url?scp=4143075666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4143075666&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2003.11.008

DO - 10.1016/j.neurobiolaging.2003.11.008

M3 - Article

VL - 25

SP - 1169

EP - 1173

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 9

ER -